ALLO
#2692
Allogene Therapeutics, Inc. - Common Stock
2.0 9 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.45%
Changement Mensuel
+20.11%
Evolution sur 6 mois
-21.72%
Changement Annuel
+77.12%
Clôture Précédente
2.0 4
Open
2.0 9
Low
2.0 9
High
2.0 9
Volume
91
Financials
- Market Capitalization 722.08 M
- Employee 152
- Founded 2017
- CEO N/A
- Website www.allogene.com
- Headquarter California, United States
- FIGI BBG00KHRRDX3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.57
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2683 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.18 USD | -0.86% | -0.11% | +6.25% | -4.87% | 736.00 M USD | ||
| 2691 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.94 USD | +1.94% | +3.59% | -25.00% | -28.25% | 723.25 M USD | ||
| 2699 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.70 USD | +2.03% | +0.77% | +23.03% | +113.99% | 717.46 M USD | ||
| 2707 |  ASMB Assembly Biosciences, Inc. - Common Stock | 34.80 USD | -1.75% | +2.78% | +35.15% | +18.27% | 708.55 M USD |